Figure 6.7
Delivery devices supplied by wholesalers for the administration of short-acting beta agonist and anticholinergic medication, by defined daily dose (DDD) per 1,000 persons per day, Australia, 1996–2004
Sources: IMS Health; Australian Bureau of Statistics.
Data table
Year | Metered dose inhaler |
Dry powder inhaler |
Nebuliser solution |
Oral |
1996 |
36.63 |
5.60 |
13.48 |
0.55 |
1997 |
36.08 |
5.46 |
13.48 |
0.47 |
1998 |
36.72 |
5.18 |
13.53 |
0.41 |
1999 |
37.82 |
5.20 |
13.92 |
0.38 |
2000 |
36.45 |
4.84 |
13.22 |
0.32 |
2001 |
35.28 |
4.40 |
11.92 |
0.26 |
2002 |
34.24 |
3.99 |
10.91 |
0.17 |
2003 |
31.77 |
3.59 |
8.03 |
0.16 |
2004 |
28.39 |
3.28 |
6.28 |
0.14 |
© Australian Institute of Health and Welfare 2005